An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma
Clinical trial NCT03329846 · COMPLETED
Trial details
- NCT number
- NCT03329846
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2020-07-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.